Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › COHANCE

COHANCE

Cohance Lifesciences Limited
Small-capHealthcare ↗

What the six lenses say about COHANCE — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹440.1
2026-07-10
VWAP · 1Y anchor
₹522
-15.7% from VWAP
P/E · TTM
93.8×
TTM EPS ₹4.7
52-week range
20%
position low→high
RSI(14)
51
momentum

Own sector index

Healthcare ↗
Overweight

1M

+5.5%

3M

+14.9%

1Y

+12.8%

Breadth >EMA21

68%

How COHANCE’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
7.0
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD445›

The actual numbers

Price vs VWAP (1y)-15.7%
EMA trend stackMixed
Price vs 200-EMA-16.1%
Price vs 50-EMA+2.6%
RSI(14)51
RS vs Nifty 500 · 3M+13.2%
RS vs sector · 3M+1.6%
52-week range20%
Volume vs 30d avg0.34×
Volume vs 60d avg0.16×
ATR(14) · volatility20.6
Bollinger width · vol contraction0.158
FundamentalD551›

The actual numbers

Return on equity (ROE)7.0%
Return on capital (ROCE)8.3%
Operating margin10.8%
Net margin6.6%
Revenue growth · YoY+38.7%
EPS growth · YoY-65.5%
Debt / equity0.10×

Full 8-quarter history in the financials table below.

ValuationD421›

The actual numbers

P/E (TTM)93.8×
TTM EPS₹4.7
52-week range20%
CatalystD434›

The actual numbers

Earnings & momentum36
Capital actions0
Governance96

Every filing in the corporate-announcements panel below.

FlowD1062›

The actual numbers

Promoter holding57.5%
Delivery · 30d avg43.7%
Up/down-day asymmetry-4.7pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D4 + D10 ) ÷ 2 = 7.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Medium
47
Conviction score 47/100 · avg-decile strength 7.0/10
Conviction score47/100›
TechnicalD4›
FundamentalD5›
ValuationD4›
CatalystD4›
FlowD10›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+1.8pp
-1.9pp
-1.0pp
+16.8pp
-0.8pp
-50.3pp
Nifty 500
Broad-market baseline
+1.4pp
-2.0pp
-1.6pp
+13.2pp
-5.9pp
-54.1pp
Sector
Own-sector index
—
—
-3.3pp
+1.6pp
-18.7pp
-68.6pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

COHANCE daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
440.15+9.35

Relative strength

RS vs baseline · rebased to 100

COHANCE ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
53.50+0.74

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)231258307840549556545619
↳ change QoQ—+11.7%+19.2%+173.6%-34.6%+1.1%-2.0%+13.7%
EBITDA (₹cr)981181332291121219599
EBITDA margin42.5%45.8%43.4%27.3%20.4%21.8%17.5%15.9%
PAT (₹cr)6182831174666298
↳ change QoQ—+34.9%+1.6%+40.7%-60.4%+43.1%-56.3%-71.4%
Net margin26.3%31.8%27.1%13.9%8.5%11.9%5.3%1.3%
EPS (₹)2.393.233.264.731.281.940.960.51
D/E————————
YoY growth · Mar '26Revenue -26.3% YoYPAT -92.9% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 18 Jun '26
    MEDIUMgovernance
    Resignation of Director/KMP/SMP
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 17 Jun '26
    MEDIUMgovernance
    Resignation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 12 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 6 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Apr '26
    LOWgovernance
    Price movement
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Apr '26
    LOWgovernance
    Price movement
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 Apr '26
    MEDIUMgovernance
    Resignation of Director/KMP/SMP
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 Apr '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 Apr '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds COHANCE

Mutual funds holding COHANCE (10)

FundWeightAUM ₹crGrade
DSP Large & Mid Cap Fund Reg Gr0.69%17,370
DSP ELSS Tax Saver Reg Gr0.88%16,156
DSP Flexi Cap Fund Reg Gr0.90%11,798
ICICI Pru Pharma Healthcare Diag Gr4.31%6,454
Aditya BSL Large & Mid Cap Gr0.53%5,666
SBI Healthcare Opportunities Reg Gr2.01%4,998
Invesco India Flexi Cap Reg Gr0.60%4,956
DSP Healthcare Fund Reg Gr4.15%3,309
DSP Multicap Reg Gr1.06%2,809
UTI Healthcare Reg Gr2.44%1,308

ETFs holding COHANCE (2)

ETFWeightGrade
Zerodha Nifty Smallcap 100 ETF0.64%
Mirae Asset Nifty 500 Healthcare ETF0.56%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare